Jerzy W Łazarewicz Selected Research

S- (4- fluorophenyl)- (3- (3- (4- fluorophenyl)- (1,2,4)- oxadiazol- 5- yl)piperidin- 1- yl)methanone

1/2015

Effects of mGluR5 positive and negative allosteric modulators on brain damage evoked by hypoxia-ischemia in neonatal rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jerzy W Łazarewicz Research Topics

Disease

5	Hypoxia (Hypoxemia) 01/2015 - 11/2002
3	Brain Ischemia (Cerebral Ischemia) 01/2015 - 05/2006
3	Ischemia 01/2015 - 05/2006
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2012 - 01/2005
1	Memory Disorders (Memory Loss) 01/2012
1	Acute Disease 01/2012
1	Asphyxia (Suffocation) 09/2009
1	Neoplasms (Cancer) 04/2004

Drug/Important Bio-Agent (IBA)

2	CalciumIBA 01/2012 - 11/2002
1	fenobamIBA 01/2015
1	S- (4- fluorophenyl)- (3- (3- (4- fluorophenyl)- (1,2,4)- oxadiazol- 5- yl)piperidin- 1- yl)methanoneIBA 01/2015
1	Antidepressive Agents (Antidepressants)IBA 01/2015
1	Neuropeptide YIBA 01/2015
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2015
1	Metabotropic Glutamate 5 ReceptorIBA 01/2015
1	Polychlorinated Biphenyls (PCBs)IBA 01/2012
1	Glutamic Acid (Glutamate)FDA Link 09/2009
1	Calcitriol (Calcijex)FDA LinkGeneric 09/2009
1	metabotropic glutamate receptor type 1IBA 05/2006
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2005
1	Calbindin 2IBA 04/2004
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2002